These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 32418493)
1. A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy. Miron A; Lafreniere-Roula M; Steve Fan CP; Armstrong KR; Dragulescu A; Papaz T; Manlhiot C; Kaufman B; Butts RJ; Gardin L; Stephenson EA; Howard TS; Aziz PF; Balaji S; Ladouceur VB; Benson LN; Colan SD; Godown J; Henderson HT; Ingles J; Jeewa A; Jefferies JL; Lal AK; Mathew J; Jean-St-Michel E; Michels M; Nakano SJ; Olivotto I; Parent JJ; Pereira AC; Semsarian C; Whitehill RD; Wittekind SG; Russell MW; Conway J; Richmond ME; Villa C; Weintraub RG; Rossano JW; Kantor PF; Ho CY; Mital S Circulation; 2020 Jul; 142(3):217-229. PubMed ID: 32418493 [TBL] [Abstract][Full Text] [Related]
2. Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids). Norrish G; Ding T; Field E; Ziólkowska L; Olivotto I; Limongelli G; Anastasakis A; Weintraub R; Biagini E; Ragni L; Prendiville T; Duignan S; McLeod K; Ilina M; Fernández A; Bökenkamp R; Baban A; Kubuš P; Daubeney PEF; Sarquella-Brugada G; Cesar S; Marrone C; Bhole V; Medrano C; Uzun O; Brown E; Gran F; Castro FJ; Stuart G; Vignati G; Barriales-Villa R; Guereta LG; Adwani S; Linter K; Bharucha T; Garcia-Pavia P; Rasmussen TB; Calcagnino MM; Jones CB; De Wilde H; Toru-Kubo J; Felice T; Mogensen J; Mathur S; Reinhardt Z; O'Mahony C; Elliott PM; Omar RZ; Kaski JP JAMA Cardiol; 2019 Sep; 4(9):918-927. PubMed ID: 31411652 [TBL] [Abstract][Full Text] [Related]
3. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). O'Mahony C; Jichi F; Pavlou M; Monserrat L; Anastasakis A; Rapezzi C; Biagini E; Gimeno JR; Limongelli G; McKenna WJ; Omar RZ; Elliott PM; Eur Heart J; 2014 Aug; 35(30):2010-20. PubMed ID: 24126876 [TBL] [Abstract][Full Text] [Related]
4. Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy. Norrish G; Ding T; Field E; Cervi E; Ziółkowska L; Olivotto I; Khraiche D; Limongelli G; Anastasakis A; Weintraub R; Biagini E; Ragni L; Prendiville T; Duignan S; McLeod K; Ilina M; Fernández A; Marrone C; Bökenkamp R; Baban A; Kubus P; Daubeney PEF; Sarquella-Brugada G; Cesar S; Klaassen S; Ojala TH; Bhole V; Medrano C; Uzun O; Brown E; Gran F; Sinagra G; Castro FJ; Stuart G; Vignati G; Yamazawa H; Barriales-Villa R; Garcia-Guereta L; Adwani S; Linter K; Bharucha T; Garcia-Pavia P; Siles A; Rasmussen TB; Calcagnino M; Jones CB; De Wilde H; Kubo T; Felice T; Popoiu A; Mogensen J; Mathur S; Centeno F; Reinhardt Z; Schouvey S; O'Mahony C; Omar RZ; Elliott PM; Kaski JP Circ Arrhythm Electrophysiol; 2022 May; 15(5):e010075. PubMed ID: 35491873 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis. Norrish G; Cantarutti N; Pissaridou E; Ridout DA; Limongelli G; Elliott PM; Kaski JP Eur J Prev Cardiol; 2017 Jul; 24(11):1220-1230. PubMed ID: 28482693 [TBL] [Abstract][Full Text] [Related]
6. Validation of the 2014 European Society of Cardiology Sudden Cardiac Death Risk Prediction Model Among Various Phenotypes in Japanese Patients With Hypertrophic Cardiomyopathy. Nakagawa S; Okada A; Nishimura K; Hamatani Y; Amano M; Takahama H; Amaki M; Hasegawa T; Kanzaki H; Kusano K; Yasuda S; Izumi C Am J Cardiol; 2018 Dec; 122(11):1939-1946. PubMed ID: 30293654 [TBL] [Abstract][Full Text] [Related]
7. A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy. Norrish G; Ding T; Field E; McLeod K; Ilina M; Stuart G; Bhole V; Uzun O; Brown E; Daubeney PEF; Lota A; Linter K; Mathur S; Bharucha T; Kok KL; Adwani S; Jones CB; Reinhardt Z; Omar RZ; Kaski JP Europace; 2019 Oct; 21(10):1559-1565. PubMed ID: 31155643 [TBL] [Abstract][Full Text] [Related]
8. The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy. Conway J; Min S; Villa C; Weintraub RG; Nakano S; Godown J; Tatangelo M; Armstrong K; Richmond M; Kaufman B; Lal AK; Balaji S; Power A; Baez Hernandez N; Gardin L; Kantor PF; Parent JJ; Aziz PF; Jefferies JL; Dragulescu A; Jeewa A; Benson L; Russell MW; Whitehill R; Rossano J; Howard T; Mital S Circulation; 2023 Feb; 147(9):718-727. PubMed ID: 36335467 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator. Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675 [TBL] [Abstract][Full Text] [Related]
11. External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy. Norrish G; Qu C; Field E; Cervi E; Khraiche D; Klaassen S; Ojala TH; Sinagra G; Yamazawa H; Marrone C; Popoiu A; Centeno F; Schouvey S; Olivotto I; Day SM; Colan S; Rossano J; Wittekind SG; Saberi S; Russell M; Helms A; Ingles J; Semsarian C; Elliott PM; Ho CY; Omar RZ; Kaski JP Eur J Prev Cardiol; 2022 Mar; 29(4):678-686. PubMed ID: 34718528 [TBL] [Abstract][Full Text] [Related]
12. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410 [TBL] [Abstract][Full Text] [Related]
13. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy. O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826 [TBL] [Abstract][Full Text] [Related]
14. Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention. Yazaki K; Suzuki A; Shiga T; Minami Y; Arai K; Ashihara K; Shoda M; Hagiwara N BMC Cardiovasc Disord; 2021 Feb; 21(1):106. PubMed ID: 33607967 [TBL] [Abstract][Full Text] [Related]
15. International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM). O'Mahony C; Jichi F; Ommen SR; Christiaans I; Arbustini E; Garcia-Pavia P; Cecchi F; Olivotto I; Kitaoka H; Gotsman I; Carr-White G; Mogensen J; Antoniades L; Mohiddin SA; Maurer MS; Tang HC; Geske JB; Siontis KC; Mahmoud KD; Vermeer A; Wilde A; Favalli V; Guttmann OP; Gallego-Delgado M; Dominguez F; Tanini I; Kubo T; Keren A; Bueser T; Waters S; Issa IF; Malcolmson J; Burns T; Sekhri N; Hoeger CW; Omar RZ; Elliott PM Circulation; 2018 Mar; 137(10):1015-1023. PubMed ID: 29191938 [TBL] [Abstract][Full Text] [Related]
16. Inverted U-Shaped Relation Between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy. O'Mahony C; Jichi F; Monserrat L; Ortiz-Genga M; Anastasakis A; Rapezzi C; Biagini E; Gimeno JR; Limongelli G; McKenna WJ; Omar RZ; Elliott PM; Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27217341 [TBL] [Abstract][Full Text] [Related]
17. Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy. Liu J; Wu G; Zhang C; Ruan J; Wang D; Zhang M; Wang L; Yang Y; Li X; Wang Y; Hui R; Zou Y; Kang L; Wang J; Song L Heart Rhythm; 2020 Oct; 17(10):1658-1663. PubMed ID: 32311532 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study. Balaji S; DiLorenzo MP; Fish FA; Etheridge SP; Aziz PF; Russell MW; Tisma S; Pflaumer A; Sreeram N; Kubus P; Law IH; Kantoch MJ; Kertesz NJ; Strieper M; Erickson CC; Moore JP; Nakano SJ; Singh HR; Chang P; Cohen M; Fournier A; Ilina MV; Smith RT; Zimmerman F; Horndasch M; Li W; Batra A; Liberman L; Hamilton R; Janson CM; Sanatani S; Zeltser I; McDaniel G; Blaufox AD; Garnreiter JM; Katcoff H; Shah M Heart Rhythm; 2019 Oct; 16(10):1462-1467. PubMed ID: 31026510 [TBL] [Abstract][Full Text] [Related]
19. Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario. Weissler-Snir A; Allan K; Cunningham K; Connelly KA; Lee DS; Spears DA; Rakowski H; Dorian P Circulation; 2019 Nov; 140(21):1706-1716. PubMed ID: 31630535 [TBL] [Abstract][Full Text] [Related]
20. Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablation. Liebregts M; Faber L; Jensen MK; Vriesendorp PA; Hansen PR; Seggewiss H; Horstkotte D; Adlova R; Michels M; Bundgaard H; Ten Berg JM; Veselka J Europace; 2018 Sep; 20(FI2):f198-f203. PubMed ID: 29016960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]